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ABSTRACT: Within the kidney, angiotensin II (AngII) targets different cell types in the vasculature, tubuli, and
glomeruli. An important part of the renal filtration barrier is composed of podocytes with their actin-rich foot
processes. In this study, we used stable isotope labeling with amino acids in cell culture coupled to mass spec-
trometry to characterize relative changes in the phosphoproteome of human podocytes in response to short-term
treatment with AngII. In 4 replicates, we identified a total of 17,956 peptides that were traceable to 2081 distinct
proteins. Bioinformatic analyses revealed that among the increasingly phosphorylated peptides are predominantly
peptides that are related to actin filaments, cytoskeleton, lamellipodia,mammalian target of rapamycin, andMAPK
signaling. Among others, this screening approach highlighted the increased phosphorylation of actin-bundling
protein, L-plastin (LCP1). AngII-dependent phosphorylation of LCP1 in cultured podocytes was mediated by the
kinases ERK, p90 ribosomal S6 kinase, PKA, or PKC. LCP1 phosphorylation increased filopodia formation. In
addition, treatmentwithAngII led to LCP1 redistribution to the cell margins, membrane ruffling, and formation of
lamellipodia. Our data highlight the importance of AngII-triggered actin cytoskeleton-associated signal trans-
duction inpodocytes.—Schenk, L.K.,Mo¨ller-Kerutt,A.,Klosowski,R.,Wolters,D., Schaffner-Reckinger, E.,Weide,
T., Pavensta¨dt,H.,Vollenbro¨ker, B.Angiotensin II regulatesphosphorylation of actin-associatedproteins inhuman
podocytes. FASEB J. 31, 000–000 (2017). www.fasebj.org
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The glomerular filtration barrier in the kidney is among
those composed of podocytes with interdigitating actin-
based processes. These podocyte foot processes with the
interposed slit diaphragm play an important role in
maintaining the selective permeability of the glomerular
filtration barrier that retains large proteins but freely filters
water, electrolytes, andsmallmolecules (1).During the last
decade, it has become clear that podocyte injury is asso-
ciated with proteinuria (1–3).
The peptide hormone, angiotensin II (AngII), is amajor
component of the renin-angiotensin-aldosterone system
(RAAS) and, thus, a crucial regulator of blood pressure,
salt-water balance, sympathetic nervous system, and
tissue homeostasis (4). AngII mediates the vasocon-
striction of the efferent glomerular arteriole, thereby
physiologically regulating the glomerular filtration rate
(5). High levels of AngII and sustained RAAS activation
are crucial factors in the pathogenesis of glomerular
injury (6), and AngII is a major profibrotic cytokine that
leads to glomerulosclerosis (7). Clinical studies have
proven that AngII receptor 1 (AT1R) blocker and
angiotensin-converting enzyme inhibitors have a ben-
eficial effect on proteinuria and inhibit the progression
of kidney disease (8). Indeed, administration of these
drugs is associated with lower mortality in patients
with chronic kidney disease (9).
The AngII receptor, AT1R, is a GPCR. Upon receptor
activation via AngII stimulation, the intracellular C ter-
minus of AT1R couples to G proteins, such as Gq/11, Gi,
G12, and G13, thereby inducing various secondmessenger
pathways, such as PLC/inositol trisphosphate, reactive
oxygen species, calcium, and protein kinase signaling (10,
11). It has also been shown that AngII has direct effects on
the actin cytoskeleton rearrangement of podocytes. The
integrity of the actin cytoskeleton is important for the
physiologic function of podocytes, and actin cytoskel-
eton deregulation may result in podocyte disease (12);
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however, the molecular details of AngII-dependent sig-
naling cascades in podocytes are not yet fully understood.
In this study, we focused on AT1R-mediated protein ki-
nase signaling and investigated which phosphorylation
sites were regulated during short-term treatment with
AngII in AT1R-expressing human podocytes.
Our data analyses revealed an over-representation of
actin-associated proteins among regulated phosphoryla-
tion sites. Among other proteins, AngII stimulation in-
duced the phosphorylation of L-plastin (LCP1). The actin
bundling protein, LCP1, is known for its important role in
the regulation of the actin cytoskeleton of leukocytes and
solid tumor cells (13), and we now can add several novel
aspects of LCP1 regulation in podocytes.
MATERIALS AND METHODS
Cell culture and stable isotope labeling with amino
acids in cell culture
Human immortalized podocytes (AB8/13; kindly provided by
M. Saleem, School of Clinical Sciences, University of Bristol,
Bristol, United Kingdom), the Retro-X packing cell line GP2-293,
andHEK293 cells (ThermoFisher Scientific,Waltham,MA,USA)
were cultivated at standard conditions as previously described
(14, 15). Generation and characterization of stably transfected
AB8 3F-AT1R cell lines has been previously described (14). For
relative quantification of the phosphoproteome, AB8 3F-AT1R
podocytes were grown in stable isotope labeling with amino
acids in cell culture (SILAC) (16) culture medium that contained
amino acids arginine and lysine labeled with stable isotopes
(heavy: [13C]6 [
15N]4 arginine, [
13C]6 lysine; light: [
12C]6 [
14N]4
arginine, [12C]6 lysine) for 3 passages. This labeling period is
sufficient to achieve.98% saturation of labeling (17). On the day
of theexperiment, 1 setof cellswas treatedwithAngII (100nMfor
15 min; Sigma-Aldrich, St. Louis, MO, USA), another with ve-
hicle, and then samples were pooled 1:1 (AngII/vehicle). In 2
biological replicates, cells that were grown in medium with
heavy isotopes of amino acids were treated with AngII, and in 2
replicates cells that were grown in light isotopes were treated.
Sample purification and liquid
chromatography–tandem mass spectrometry
After filter-aided sample preparation (18), TiO2 microcolumn
phosphopeptide enrichment was performed (19). Samples were
loaded onMudPIT columns as previously descibed (20). Kinetex
C18 (Phenomenex, Torrance, CA, USA) was used as material for
reversed phase chromatography. The HPLC program consisted
of 17 varying steps with 200 min each, culminating in a total
duration of 30 h. The first 3 steps used a linear gradient of ace-
tonitrile only (buffer B: 0.1% formic acid; bufferA:H2O) followed
by 11 salt steps with the concentration increased 10% each for
buffer C (250 mM ammonium acetate), with linear acetonitrile
gradients in between. Three steps of high buffer D (1.5 M am-
monium acetate) concentration followed at the end. The follow-
ing parameterswere used for themass spectrometric analysis via
LTQOrbitrapvelos (ThermoFisher Scientific): ionization voltage
of 1.8 kV; capillary temperature of 200°C; tandem mass spec-
trometry fragmentations of the 20most intense signals; dynamic
mass exclusion of 60 s;maximumorbitrap fill time of 500ms in
positive ion mode; maximum ion trap fill time of 100 ms; and
collision-induced dissociation at 35 V. Collected data were
filtered and examined by using MaxQuant software (21). The
following parameters differ from the standard settings of
MaxQuant 1.5.2.8: decoy mode reward; minutes score for
modified peptides 0; minutes d score for modified peptides 0;
and discard unmodified counterpart peptides false. In total,
we analyzed 4 biological replicates with 3 technical replicates
each. After peptide assignment using MaxQuant software as
specified above, results from all 12 samples were compiled in
1 spreadsheet.
Peptides were crosschecked to exclude ambiguous protein
assignments. In total, 17,956 peptide assignments were included
in the analyses. The median of all peptide quantifications was
1.01. For additional analyses, we focused on subsets of peptides,
specifically those with altered abundance upon treatment with
AngII. To get a general impression, a liberal cutoff of phospho-
peptide ratios of .1.5 or ,0.67 for increase or decrease, re-
spectively,was chosen [inparallelwithLefkowitz andcolleagues
(22)]. Of peptides, 15,242 had an AngII-to-vehicle ratio of .0.67
and,1.5. Fourhundred sixty-fivepeptide ratioswere,0.67, and
2249 were .1.5. Supplemental Table 1 gives a transparent
overview of peptide abundance and quantification result.
Functional analyses
Functional annotation was performed with David Gene Ontol-
ogy (https://david.ncifcrf.gov/summary.jsp and http://reactome.org)
(23). Thesedatabasesprovide information about gene andprotein
attributes that are chiefly obtainedbydatamining and that enable
the user to perform enrichment analyses. Phosphosite analyses
wereperformedwithPhosphoLogo (https://hpcwebapps.cit.nih.gov/
PhosphoLogo/) (24). Kinase substrates were analyzed in compari-
son with phosphosite analyses (http://www.phosphosite.org/) (25).
Western blot
Immunoblotting was carried out as described previously
(14, 26). Antibodies for ERK, phospho-ERK1/2, GAPDH,
phospho–p90 ribosomal S6 kinase (RSK) T359, and RSK1/2/
3were fromCell Signaling Technology (Danvers,MA,USA).
Abs for actin, b-tubulin, FLAG, and FLAG (M2) were obtained
from Sigma-Aldrich. Ab against LCP1 was obtained from
Thermo Fisher Scientific. The generation of the Ab against
phospho-LCP1 (Ser5) was described previously (27). All
primary Abs with the exception of LCP1 (1:200) were used in
a 1:1000 dilution.
Where indicated, cellswere treatedwithAngII,ATP, losartan,
and LPS (all from Sigma-Aldrich); Rp-8-Br-cAMP (Biolog, Bre-
men, Germany); U0126 (Cell Signaling Technology); BID1870
(Enzo Life Sciences, Lo¨rrach, Germany); or GF109203 (Cayman
Chemical, Ann Arbor, MI, USA).
Quantification of Western blot signals
Signals that were derived from the same immunoblot were
densitometrically quantifiedbyusing ImageJ (National Institutes
of Health, Bethesda, MD, USA). Quotients from signals of
phospho-specific Abs and from the complete amount of protein
are shown. Evaluationwas performedbyusingGraphPadPrism
(GraphPad Software, La Jolla, CA, USA). All data show the SD of
at least 3 independent experiments and were analyzed by using
unpaired Student’s t test.
Immunofluorescence
Stainingwasperformedaspreviouslydescribed (14).Absagainst
LCP1 (1:100) and Alexa Fluor 488 Phalloidin (1:200) were pur-
chased from Thermo Fisher Scientific. Ab against T-plastin (1:50)
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was from GeneTex (Irvine, CA, USA). Samples were examined
with anAxioObserver Z1microscope andApoTome technology
(Carl Zeiss AG, Oberkochen, Germany; objective: EC Plan Neo-
fluar340/1.30*Oil DIC M27) using Axio Vision 4.7.
Aggregation assay
AB8 3F-AT1R cells were detached by using Accutase (Sigma-
Aldrich) and diluted in aggregation buffer (1.25 mM CaCl2,
10 mM HEPES, 0.1% bovine serum albumin at physiologic os-
molarity and pH) to a density of 63105 cells/ml. Cells were
allowed to aggregate during shaking (80 rpm, 33°C) with or
without the addition of 100 nMAngII. Cell diameter, single cells,
and cell aggregates of treated and control cells were calculated
with the Luna Cell Counter (Logos Biosystems, Villeneuve
d’Ascq, France) after 0 and 30 min of incubation.
Cloning of LCP and T-plastin mutants
and transfection
HumanLCP1 cDNAwas amplified froma human immortalized
podocyte library (LCP1_fwd: 59-CACCGGGCGCGCCATGGC-
CAGAGGATCA GTGTCCGATGAG-39, LCP1_rev: 59-TTAAT-
TAATCACACCCTCTTCATTCCTTTCCCC-39), inserted into
pENTR-D/TOPO vector and then cloned into the pmRFP-C2
vector [backbone manufacturer: R. Y. Tsien (28)], which allows
thevisualizationof red fluorescent protein (RFP)–taggedLCP1 in
fixed cells and in life cell experiments. Phosphorylation variants
LCP1 S5A and LCP1 S5E were generated by using different for-
ward primers during amplification, changing Ser5 into alanine
(S5A: 59-CACCGGGCGCGCCATGGCCAGAGGAGCAGTG-
TCCGATGAG-39) or changing Ser5 into glutamic acid (S5E: 59-
CACCGGGCGCGCCATGGCCAGAGGAGAAGTGTCCGAT-
GAG-39). Deletion mutants were cloned with primers binding
behind the LCP1 EF hand motifs, LCP1_minusEF (59-CACCGG-
GCGCGCCGATGTTGCCAAGACCTTTAGAAAAGC-39),
amplifying AA 85–628, or LCP1_phospho_minusEF (59-
CACCGGGCGCGCCATGGCCAGAGGATCAGTGTCCGA-
TGAGGAAATGATGGAGCTCAGAGATGTTGCCAAGACC-
TTTAGAAAAGC-39), amplifying AA 1–15 + 85–628. Human
T-plastin cDNA was also amplified from the human immor-
talized podocyte library by using the primers WT_fwd (59-
CACCGGGCGCGCCATGGATGAGATGGCTACCACTCA-
GATT-39) andWT_rev (59-TTAATTAATTACACTCTCTTCATTC-
CCCTGCC-39). For amplification of the deletion mutant,
T-plastin_minusEF, the forward primer was replaced with the
primer minusEF-fwd (59-CACCGGGCGCGCCATTGCCAA-
GACCTTCCGCAAAGCAATCAACAGG-39). Amplified DNA
wasalsocloned into thepmRFP-C2vector.Transient transfectionof
podocytes was performed by using Lipofectamine 2000 (Thermo
Fisher Scientific) according to the manufacturer’s instructions.
Quantification of filopodia length and amount
RFP signals in immunofluorescence images of cells transfected
withpRFP-LCP1-WT(wild-type), pRFP-LCP1-S5A,pRFP-LCP1-
S5E, and pEGFP-C2 empty vector (mock) were analyzed by
using the filopodia code inMatLab (MathWorks, Natick, MA,
USA) as described in detail by Nilufar et al. (29). The number of
filopodia per cell and the average length of filopodia in trans-
fected cells were calculated.
Live cell imaging
For live cell imaging,AB8 3F-AT1Rpodocyteswere seededonan
Ibidi m-Dish 35-mm high with glass bottom (Ibidi, Martinsried,
Germany) and transiently transfectedwith the different pmRFP-
LCP1 or pmRFP–T-plastin constructs. Using the microscope
mentioned above, approximately 40 time-lapse images of trans-
fected cells 48 h after transfection were taken every 20 s, starting
with stimulation with 100 nM AngII directly under the micro-
scopeafter the fifth image (video time, 13min).Anadditional end
point photo was obtained 15min after stimulation. For blockade
ofAT1R, transfected cellswerepreincubated for 2hwith losartan
(10 mM) or for inhibition of RSK with BID-1870 (10 mM) for 3 h
before the start of experiments.ForCa2+-reducedconditions, cells
were incubated with BAPTA-AM (10 mM, 1 h; AAT Bioquest,
Sunnyvale, CA, USA) to complex intracellular Ca2+ ions. Fur-
thermore, extracellular calcium concentration was reduced to
0.8 mM by adding an adequate amount of Ca2+-free Krebs-
Ringer solution (145 mM NaCl, 1.6 mM K2HPO4, 0.4 mM
KH2PO4, 5 mM glucose, 1 mMMgCl2, 5 mM EGTA).
RESULTS
AngII leads to quantitative changes in the
phosphoproteome of human podocytes
We chose an immortalized human podocyte cell line
(AB8/13) with robust expression of FLAG-tagged AT1R
(AB8 3F-AT1R) as a model system (14). These cells re-
semble podocytes in vivowith regard to their expression of
podocyte-specific cytoskeletal proteins, nephrin and syn-
aptopodin (30). Moreover, they can form filopodia and
lamellipodia and, as a result of their large size, they are
excellent targets for the visualization of intracellular
processes.
Temporal dynamics of phosphorylation events upon
GPCRactivation arehighly complex (31–33); therefore,we
performed time course experiments anddemonstrated the
phosphorylation of ERKwithin the first 15min afterAngII
stimulation (14). Thus, we chose this time point for our
proteomic study.
Relative quantification of AngII-dependent changes
of the cellular phosphoproteome was performed by
using SILACcoupledwith phosphopeptide enrichment
and liquid chromatography–tandemmass spectrometry
(Supplemental Fig. 1A). Accordingly, AB8 3F-AT1R cells
that were grown in SILAC culture media were treated
with AngII (100 nM) or vehicle for 15 min. An effective
AngII stimulation was demonstrated by increased ERK
phosphorylation in aWesternBlot (Supplemental Fig. 1B).
Subsequently, cell extracts were used for sample prepa-
ration, including phosphopeptide enrichment, mass
spectrometry, bioinformatic peptide assignment, and
semiquantitative quantification. With this approach, we
identified 17,956 peptides in 4 biological replicates, each
performed in 3 technical replicates. A total of 4951, 4729,
5173, and 3103 phosphopeptides was found, correspond-
ing to 1494, 1209, 1224, and 891 phosphoproteins—in
replicates 1, 2, 3, and 4, respectively (Fig. 1 and Supple-
mentalFig. 1C).After removalof redundantpeptides, 6323
unique phosphopeptides could be traced back to 2081
distinct proteins. A large proportion of 1326 proteinswere
found in at least 2 of the experiments (Fig. 1A). We ob-
served increased and decreased amounts of phospho-
peptides upon 15 min of treatment with AngII (Fig. 1B).
Among the identified phosphorylation sites, ;90% were
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phosphoserine, ;9% phosphothreonine, and ;1% phos-
photyrosine. Phosphosite analysis demonstrated that
treatment of podocytes with AngII for 15 min led to an
increased serine/threonine phosphorylation at proline-
directed sites (proline at position +1), which fits to a motif
that is predominantly used in MAPK signaling (Fig. 1C).
This sequence motif preference was reproducible for both
.1.53 and .33 increased AngII/vehicle phosphopep-
tide ratios. We next compared our data with other studies
in this field. A large proportion of the proteins that we
identified in our samples have been repeatedly found in
other renal phosphoproteomic databases, but, in addition,
we could identify several novel phospho-targets of AT1R
signaling in podocytes. In comparison to other studies, it is
interesting to overlap the phosphoproteins identified in
the podocyte cell line in our study with native glomerular
podocytes, and to evaluate parallels with studies that
characterized AngII-induced phosphoproteomic changes
in different cell types. Of proteins, 1595 from our screen
have previously been proven to be expressed in podo-
cytes by a non–phospho-enriched proteome character-
ization of primary cultured murine podocytes (34) (Fig.
1D). In another study, the relative quantification of the
AngII-dependent phosphoproteomeofAT1R-expressing
HEK293 cells was performed (35). One hundred twenty-
one of the phosphoproteins that were increased in our
study were also regulated in HEK293 cells (35), whereas
323proteinswere apparently podocyte-specific targets of
AngII phospho-signaling (Fig. 1E).
AngII increased phosphorylation of actin
filament–associated peptides
To get a general impression, a liberal cutoff of phospho-
peptide ratios of .1.5 or ,0.67 for increase or decrease,
respectively, was chosen [in parallel to Lefkowitz and
colleagues (22) and Christensen et al. (35)].
With these criteria, 85%of the total 17,956 peptides had
an AngII-to-vehicle ratio of .0.67 and ,1.5, which was
resumed as unregulated, in 2.5% the peptide ratio was
decreased (,0.67) and in 12.5% the ratio was increased
(.1.5). Four hundred twenty-six unique phosphorylation
sites were increased, 1560 were unchanged, and 41 were
decreased. Supplemental Table 1 provides an overview of
all peptide abundances and a quantification of results.
Phosphopeptides with the largest relative increase in
abundance belonged to the proteins tenascin, integrin-b6,
Figure 1. Characterization and quantitation of AngII-induced regulation of the phosphoproteome in human immortalized
podocytes. A) Venn diagram of the 2081 unique protein assignments in 4 biological replicates of AB8 3F-AT1R cells. A total of
1494, 1209, 1224, and 891 phosphoproteins were found in replicates 1, 2, 3, and 4, respectively. B) Histogram of the distribution
of peptide ratios comparing podocytes that were treated with AngII (100 nM; 15 min) vs. vehicle. For additional analyses, a liberal
cutoff of phosphopeptide ratios of .1.5 or ,0.67 for increase or decrease, respectively, was chosen. C) Analysis of the
phosphorylation site sequence motif, depicted for all peptides with a .1.5 AngII-to-vehicle ratio was performed with
PhosphoLogo. D) Venn diagram of all proteins identiﬁed in this study (AngII-PhosProt) compared with a non–phospho-enriched
proteome characterization of primary murine podocytes (cPodoProt) from Rinschen et al. (33). E) Venn diagram comparing the
phosphoproteins that were increased in this study (AngII-PhosProt) compared with phosphoproteins that were increased in a
study of AT1R signaling in HEK293 cells (HEK-AT1R) from Christensen et al. (34).
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neuroblast differentiation-associated protein, LCP1, opti-
neurin, plasminogenactivator inhibitor 1, serine/threonine
protein kinase D2, protein bicaudal C homolog 1,
phalladin, and ephrin type-A receptor 2. Table 1 sum-
marizes the 10 phosphopeptides with the largest increase
in abundance.
Quantitative changes in protein phosphorylation often
reflect the activation of distinct cellular signaling process-
es. Indeed, most of the increased phosphopeptides from
our screenwere part of signal transduction pathways (Fig.
2A). Next, gene ontology analyses and functional classifi-
cationswere used to screen our phosphoproteomic results
and to classify the regulated phosphopeptides—we used
the Database for Annotation, Visualization, and In-
tegrated Discovery (DAVID) Gene Ontology database
(http://david.abcc.ncifcrf.gov). This approach revealed that
phosphopeptides that were related to actin filaments,
lamellipodia, and cell leading edgewere over-represented
among the increasinglyphosphorylatedpeptides (Fig. 2B).
Furthermore, phosphorylation of proteins that influence
molecular functions, such as intramolecular transferase
activity and Rho GTPase activator activity, was increased
after AngII stimulation (Fig. 2C). With regard to signaling
pathways and biological processes, mammalian target of
rapamycin signaling, glucose metabolism, and focal ad-
hesion were over-represented (Supplemental Fig. 2A, B).
On the basis of the over-representationof actin-associated
pathways in our analyses and the great importance of actin
cytoskeletal dynamics for podocytes, we took a closer look
at this group of proteins and identified many phosphopep-
tides from proteins that were linked with the actin cytoskel-
eton (Table 2). A schematic overview of phosphoproteins
related to the gene ontology terms, actin filaments, lamelli-
podia, and cell leading edge is given in Fig. 2D.
AngII-induced LCP1 phosphorylation is
mediated by the kinases RSK, PKA, and PKC
Phospho-Ser5 LCP1 was one of the most enriched
peptides in our phosphoproteomic screen after 15 min
of AngII treatment in human podocytes (Table 1). The
protein LCP1 is one of 3 plastin isoforms that are found
in mammalian cells that belong to the a-actinin family
of actin cross-linking proteins, which play a crucial role
in podocyte biology. Indeed, mutations in the protein
a-actinin-4, for example, have previously been linked to
podocyte injury (36). In contrast to other a-actinin family
members, plastins have 2 actin-binding domains in a sin-
gle polypeptide chain. Cross-linking parallel actin fila-
ments into tightbundles, plastins can stabilize larger-order
F-actin structures. On the one hand, the bundling activity
of LCP1 is regulated by calcium binding at EF-hand loops
and, on the other, by serine phosphorylation sites, both of
which are included in the N-terminal region of LCP1 (13).
First, AngII-induced phosphorylation of LCP1 at Ser5
(p-LCP1)was replicated inWestern blot experimentswith
a highly specific Ab against this phosphorylation site (27).
Total LCP1 abundance remained unchanged (Supple-
mental Fig. 3). AngII-dependent phosphorylation of ERK
at the activating Thr202/Tyr204 site (p-ERK) served as
control for stimulation, and the stable expression of 3F-
AT1R served as control of the cell line. Evaluation of 4
independent experiments allowed quantification of the
AngII-dependent increase of LCP1 and ERK phosphory-
lation, shownasa ratio ofphosphorylatedproteins and the
total amount of proteins (Supplemental Fig. 3).
It is known that the extracellular stimulation ofAT1R
with AngII increases the level of intracellular calcium
and, in part as a consequence, leads to the activation
of several kinases, which transfers additional signal
transduction (10, 11). In additional experiments, we
examined the signaling pathway of AngII-induced
LCP1 phosphorylation. To investigate whether an
AngII-induced Ca2+ influx is primarily responsible
for LCP1 phosphorylation, we treated cells with ion-
omycin, which elicits a large Ca2+ increase in the cyto-
plasm of cells (37); however, an increase in intracellular
Ca2+ alone did not lead to an increase in p-LCP1 (Fig.
3A). Treatment with a high concentration of ATP,
which, similar to AngII, leads to a G protein–induced
increase of intracellular Ca2+, could, in contrast, induce
the phosphorylation of LCP1 and that of kinases ERK
and RSK (p-RSK). LPS is known as a podocyte-affecting
substance, which leads in vivo to foot process efface-
ment and damage to the slit diaphragm (38). To exam-
ine whether podocyte damage in general leads to LCP1
TABLE 1. Compilation of the 10 peptides with the largest increase in peptide ratio upon AngII stimulation (100 nM; 15 min) vs. control
Protein name Gene symbol Mean Ang/Ktr Sequence Modiﬁcation site
Tenascin-N TNN 29.45 Y*VVRY*T*SAGGETR Y650, Y654; T655
Integrin-b6 ITGB6 13.22 VGDT*AS*FSVT*VNIPHCER T414; S416; T420
Neuroblast differentiation-associated
protein AHNAK
AHNAK 8.09 LKS*EDGVEGDLGETQSR S135
L-Plastin LCP1 7.09 GS*VSDEEMMELR S5
Optineurin OPTN 5.40 HGARTS*DSDQQAYLVQR S520
Plasminogen activator inhibitor 1
RNA-binding protein
SERBP1 5.38 S*KSEEAHAEDSVMDHHFR S313
5.26 S*KS*EEAHAEDSVMDHHFR S313; S315
Serine/threonine-protein kinase D2 PRKD2 4.25 RLS*STSLAS*GHSVR S197; S203
Protein bicaudal C homolog 1 BICC1 4.21 S*PSHSGNAGDLK S633
Palladin PALLD 4.17 IAS*DEEIQGTK S669
Ephrin type-A receptor 2 EPHA2 4.08 LPS*TSGSEGVPFR S897
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Figure 2. Signaling pathways over-represented among regulated phosphoproteins. A) Analysis demonstrates that proteins
involved in signal transduction are predominant among increased phosphopeptides. B) A gene ontology functional classiﬁcation
regarding cellular components revealed that phosphopeptides related to actin ﬁlaments, lamellipodia, and cell leading edge
were over-represented among increased phosphopeptides. C) A gene ontology functional classiﬁcation revealed that
phosphopeptides related to molecular functions, such as intramolecular transferase activity and Rho GTPase activator activity,
were increased after AngII stimulation. D) Schematic representation of increased phosphoproteins associated with cellular
components cell leading edge, actin ﬁlament, and lamellipodia, as deﬁned by gene ontology terms.
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phosphorylation, cells were treated with LPS, which
resulted in a slight increase in phosphorylation.
AngII treatment, in addition to the activation of ERK
and phosphorylation of LCP1 already shown in Supple-
mental Fig. 3, led to increased phosphorylation of RSK at
Thr359. This phosphorylation of RSK and of ERK and
LCP1 could be reduced by preincubation with the AT1R
blocker losartan.
It has been demonstrated in breast cancer cell lines that
ERK,RSK,PKA, andPKCare involved in the regulationof
LCP1 phosphorylation at Ser5 (27, 39, 40); therefore, we
investigatedwhether these kinases are also responsible for
LCP1 phosphorylation in podocytes. Treatment with the
specific RSK inhibitor, BID1870 (41), or the ERK inhibitor,
U0126 (42), completely blocked AngII-induced LCP1
phosphorylation, which demonstrated that ERK and RSK
are involved in LCP1 phosphorylation also in podocytes.
The inhibitor, U0126, is an indirect ERK inhibitor and
prevented AngII-induced ERK phosphorylation (Fig. 3A)
via inhibition of the kinase MEK1/2, which usually phos-
phorylates and activates ERK (42). In contrast, the RSK
inhibitor used in this study directly inhibited RSK kinase
activity without influencing AngII-induced phosphoryla-
tion of RSK (Fig. 3A) (41).
In addition to phosphorylation via ERK and RSK, the
PKA-mediated phosphorylation of LCP1—previously
shown in breast cancer cells (39)—could be confirmed in
podocytes. Preincubation with the PKA-specific inhibitor,
RP-8-Br-cAMP (43), diminished LCP1 phosphorylation,
whereas RSK phosphorylation was preserved after treat-
ment (Fig. 3B). This result suggests that LCP1 Ser5 is not
exclusively phosphorylated by RSK but also in parallel by
PKA.
Similarly, inhibitionofPKCwith thepan-PKCinhibitor,
GF109203X (44), blocked AngII-induced LCP1 phosphor-
ylation (Fig. 3C). It also influenced RSK phosphorylation
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Figure 3. Phosphorylation of LCP1 is AngII dependent and can occur via ERK, RSK, PKA, and PKC kinases. For a more precise
examination of AngII-dependent signaling events that result in LCP1 phosphorylation, different kinase inhibitors were used. In
addition, the induction of LCP1 phosphorylation by general calcium increase (ATP, ionomycin) or podocyte damage (LPS) was
tested. A) Representative Western blot results from podocytes that were treated with AngII (100 nM, 15 min), ionomycin (500
nM, 5 min), ATP (1 mM, 5 min), or LPS (1 mM, 24 h) (left). Where indicated, cells were preincubated with AT1R blocker (Los;
10 mM, 2 h), RSK inhibitor BID1870 (10 mM, 4 h), or ERK inhibitor U0126 (10 mM, 2 h). Ratio between phosphorylated and total
amount of LCP1 from 4 independent experiments (right). B) Representative Western blot from podocytes that were treated with
AngII (100 nM, 15 min) (left). Preincubation with PKA-speciﬁc inhibitor RP-8-Br-cAMP in higher concentration diminishes AngII-
induced LCP1 phosphorylation. Ratio between phosphorylated and total amount of LCP1 from 4 independent experiments (right).
C) Representative Western blot results from podocytes that were treated with AngII (100 nM, 15 min) (left). Preincubation with the
(continued on next page)
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as treatment with GF109203X reduced the p-RSK sig-
nal; however, treatment with AngII still activates
RSK (phosphorylation of RSK), which indicated an
RSK-independent contribution of PKC to LCP1
phosphorylation.
In summary, our data indicate that AngII-induced
LCP1 phosphorylation in podocytes can occur in parallel
via activation of ERK and subsequently RSK or via an
AngII-induced PKA activation or via PKC activation, di-
rectly or indirectly via RSK or PKA (Fig. 3D).
Intracellular localization of LCP1 changes
after AngII stimulation
Immunofluorescent staining of endogenous LCP1 in
podocytes demonstrated that LCP1 colocalized, in part,
with actin, particularly in needle-like cell–cell contacts
(Fig. 4A, top). LCP1 staining in such extensions was ob-
served in a previous study and the structures were iden-
tified as filopodia (45). Indeed,wealso observedLCP1and
actin-stained filopodia forming cell–cell contacts in podo-
cytes. During AngII treatment, LCP1 and actin redis-
tributed to cell borders (Fig. 4A, bottom). Furthermore, the
morphology of cell–cell contact sites changed: the number
of needle-like structures seemed to decrease after AngII
stimulation and, instead, cell contact sites seemed to be
broadened, in parts overlapping. This observation was
confirmed in experiments with cells that were grown to
confluence. These cells were too dense to visualize filo-
podia but AngII stimulation induced membrane ruffling;
cells seemed to enlarge and grow out of the cell assembly,
forming lamellipodia (Fig. 4B). To quantify the effect of
membrane ruffling, we counted the cells with ruffled
membranes with or without AngII treatment and con-
firmed that nearly all cells reacted to AngII stimulation
with membrane ruffling (Fig. 4C).
As such actin-based changes at the plasma membrane
as filopodia or lamellipodia formation are often initial
steps for cell–cell contact formation, we applied a cell ag-
gregation assay to investigate whether AngII stimulation
influences cell–cell aggregation of podocytes. For this as-
say, cells were cultured in suspension with and without
AngII. Indeed, our experiments revealed significantly in-
creased AngII–dependent cell clustering (Fig. 4D), which
fits to previous observations made by Janji et al. (27) that
showed thatLCP1phosphorylation influences the cell–cell
contact formation in HEK293T cells.
LCP1 phosphorylation influences cell–cell
contacts and filopodia formation
It hasbeenpreviously shown thatphosphorylationofLCP1
at Ser5 promotes the targeting of LCP1 to actin assembly
sites (27, 40). To address this, we visualized endogenously
phosphorylated LCP1 (p-Ser5–LCP1) in podocytes. Stain-
ing with a highly specific Ab (27) demonstrated that
p-Ser5–LCP1 was predominantly localized at the cell pe-
riphery and in the filopodia; however, neither the in-
crease in the pLCP1 signal, nor a redistribution of pLCP1
could be shown convincingly in this immunofluorescence
experiment (Supplemental Fig. 4). Therefore, we cloned
LCP1 constructs that were taggedwith RFP to characterize
the phosphorylation-dependent change of LCP1 distribu-
tion in more detail. In addition to LCP1-WT, we cloned a
LCP1 mutant (LCP1-S5E) that mimics phosphorylation by
exchange of Ser5 with glutamic acid as well as a non-
phosphorylatable mutant (LCP1 S5A) by exchange of Ser5
with alanine. Expression of the constructs and AngII-
induced phosphorylation of RFP-tagged LCP1—similar to
endogenous LCP1—was verified in HEK293T cells (Sup-
plemental Fig. 5).
In transiently transfected podocytes, RFP-LCP1-
WT was mainly localized in the cytoplasm, colocaliz-
ing, in part, with actin. In less dense cell layers,
RFP-LCP1-WT colocalized with actin in the filopodia
in parallel to our observations of endogenous LCP1
(Figs. 4A and 5A). In cells that were transfected with
the phosphomimicking mutant, S5E, we also observed
LCP1-stained filopodia (Fig. 5A); however, the num-
ber of filopodia of cells that were transfected with
nonphosphorylatable mutant (S5A) was reduced (Fig.
5A). To confirm this observation, we evaluated the
amount and length, preferably of single cells that were
transfected with the three LCP1 constructs or with
control plasmid (Fig. 5B). In cells that were transfected
with nonphosphorylatable S5A variant, filopodia
number or length did not differ frommock-transfected
cells (Fig. 5C). In contrast, transfection with the LCP1-
S5E variant and WT increases filopodia formation in
both number and length. This indicates that LCP1
phosphorylation is crucial for filopodia formation. On
the basis of these results, we conclude that AngII-
induced LCP1 phosphorylation influences cell–cell
contact formation.
AngII-induced lamellipodia formation is
independent of LCP1 phosphorylation
AngII-induced LCP1 redistribution was studied in
more detail in live cell imaging studies of podocytes that
were transiently transfected with RFP-tagged LCP1-
WT (Fig. 6A). Addition of water did not alter the cell
shape (Fig. 6A, line 1); however, treatment with AngII
(Fig. 6A, line 2) induced membrane ruffling and di-
rected lamellipodia outgrowth at the cell periphery.
Lamellipodia outgrowth that resulted in an increase in
RFP-signals at the cell periphery was used to quantify
the AngII effect, termed cell area enlargement (Sup-
plemental Video 1; LCP1WT +AngII). Ruffling activity
pan-PKC inhibitor GF109203X completely blocked AngII-induced phosphorylation of LCP1. Ratio between phosphorylated and
total amount of LCP1 from 3 independent experiments (right). D) Schematic representation of the regulation of LCP1
phosphorylation downstream of AngII and AT1R in podocytes. Dotted lines from PKC include the possibility that LCP1 is
phosphorylated by PKC directly or mediated by PKA or RSK. Data are means6 SD, Student’s t test. *P , 0.05, **P , 0.01, ***P ,
0.001.
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and cell area enlargement persisted for the entire ob-
servation period of 15 min. This AngII-induced LCP1
redistribution could be blocked by preincubation with
the AT1R-antagonist, losartan (Fig. 6A, line 3); however,
preincubationwithRSK inhibitor,which completely inhibited
AngII-induced LCP1 phosphorylation at Ser5 (Fig. 3A),
had no influence on AngII-induced cell area enlargement
(Fig. 6A, line 4). This suggested that cell area enlargement
was not regulated by Ser5 phosphorylation. Similar effects
on cell area enlargement were observed in cells that were
Figure 4. AngII triggers the redistribution of LCP1 localization. A) Immunoﬂuorescent staining of endogenous LCP1 (red) and
actin (phalloidin, green) before and 15 min after stimulation with AngII (100 nM) indicates an AngII-dependent redistribution
of LCP1 to the cell margins in podocytes. Details illustrate the needle-like cell–cell contacts in unstimulated cells, which seemed
to be broadened, in part overlapping, after AngII stimulation. B) AngII treatment leads to the formation of membrane rufﬂes at
cell margins, especially remarkable in LCP1 staining. C) Quantiﬁcation of cells with rufﬂed membranes evaluated from untreated
cells (n = 215) and cells after AngII treatment (n = 169; 100 nM, 15 min). D) Cells were cultured in suspension with and without
AngII (100 nM). Single cells and cell clusters of treated and control cells were calculated after 30 min incubation. Scale bars,
20 mm. Data are means 6 SD, Student’s t test. *P , 0.05, **P , 0.01, ***P , 0.001.
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Figure 5. LCP1 phosphorylation inﬂuences ﬁlopodia formation. Podocytes were transfected with ﬂuorescence-labeled (RFP)
LCP1-WT, a LCP1 mutant (LCP1-S5E) that mimics phosphorylation and a nonphosphorylatable mutant (LCP1-S5A). A)
Immunoﬂuorescence images of podocytes that were transfected with 3 LCP1 mutants also stained against actin (phalloidin,
green). Details show differences in cell–cell contact sites dependent on the transfected LCP1 mutant. B) Representative cells of
podocytes that were transfected with 3 LCP1 mutants showing differences in ﬁlopodia number and length. C, D) Quantiﬁcation
of the number and length of ﬁlopodia in podocytes that were transfected with 3 LCP1 mutants compared with control-transfected
cells (n $ 3, means 6 SD, Student’s t test). Scale bars, 20 mm. *P , 0.05, **P , 0.01, ***P , 0.001.
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Figure 6. AngII-induced LCP1 redistribution and membrane rufﬂing is independent of LCP1 phosphorylation. A) Representative
live cell imaging experiment of podocytes that were transiently transfected with ﬂuorescent RFP-LCP1-WT. Stimulation of cells
was performed in line 1 by adding water as control, and in lines 2–4 by adding AngII (100 nM). For original movie of line 2 see
the Supplemental Data. Cells in line 3 were incubated before stimulation with AT1R blocker losartan (Los; 10 mM, 2 h), and cells
in line 4 were incubated with the RSK inhibitor BID1870 (10 mM, 3 h). The image labeled 0 min was taken before stimulation,
(continued on next page)
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transfected with LCP1-S5A and LCP1-S5E mutants (Fig.
6B) which confirmed that this effect is independent of
phosphorylation.
To quantify cell area enlargement, we measured the
area of cells that were transfected with RFP-tagged
LCP1 mutants before AngII treatment and 15 min after
AngII stimulation. Changes in these areas were sum-
marized as the ratio of cell areas of stimulated vs.
unstimulated cells (Fig. 6C). With this ratio as readout,
an objective quantification of cell enlargement was
possible, which allowed a comparison of different ex-
periments. Here, our evaluation confirmed an AngII-
induced cell enlargement in podocytes, which is in-
dependent of LCP1 phosphorylation.
Ca2+-binding EF hand motifs of LCP1
are crucial for AngII-induced
lamellipodia formation
In addition to the activation of several kinases that leads to
the phosphorylation of various proteins, extracellular
stimulation of AT1R with AngII increases the level of in-
tracellular calcium (10, 11). LCP1 has two EF hand motifs
near the N-terminus that negatively regulate the actin
bundling activity of LCP1 by calcium binding (46, 47).
Therefore, we hypothesized that membrane ruffling and
lamellipodia formation after AngII stimulation could also
be regulated by the Ca2+ binding ability of LCP1 and
cloned two LCP1 deletionmutants, one of which lacks the
complete N-terminus (LCP1_minus EF) and the other
which lacks the EF hand motifs (LCP1_phospho_minus
EF; Fig. 7A). The effects of these deletions were examined
in live cell imaging studies (Fig. 7B). We again used cell
area enlargement as readout. In contrast to LCP1-WT,
AngII stimulation did not lead to cell area enlargement in
cells that expressed the deletion mutants, despite LCP1
redistribution and membrane ruffling. The presence or
absence of the phosphosite made no difference. The same
effectwasachievedwithLCP1-WT–transfected cellswhen
intracellular and extracellular Ca2+ concentrations were
reduced.Quantificationof cell enlargement confirmed this
observation (Fig. 7C). These results indicate that AngII-
induced lamellipodia formation in LCP1-transfected podo-
cytes ismainly regulatedby the increase in intracellularCa2+
concentration. Additional experiments demonstrate that
AngII can also regulate T-plastin in a calcium-dependent
manner (Supplemental Fig. 6).
However, our data strongly indicate that LCP1—in
contrast to other members of the plastin family—is
regulated by 2 different AngII-dependent mechanisms.
First, via activation of various serine/threonine kinases,
and second, via increased Ca2+-influx, which suggests
that the regulation of LCP1 is more complex than that
of other members of the plastin family—I-plastin and
T-plastin—that lack the phosphorylation site at the
N-terminus.
Taken together, ourdata indicate thatAngII-dependent
phosphorylation of actin-associated proteins occurs via
ERK, RSK, PKA, and PKC kinases. Focusing on LCP1,
our study highlights that AngII can influence protein
activity by different effects—Ca influx and activation of
kinases—indicating that AngII influences cytoskeletal
dynamics inpodocyteswithinacomplexand,presumably,
finely tuned signaling network.
DISCUSSION
The fate and function of podocytes are based on their
complex architecture and, in particular, on the integrity of
their actin cytoskeleton (48). It has been suggested that
changes in the actin cytoskeleton and intracellular Ca2+
play a major role in the morphogenesis and pathology of
podocytes (49). Global reorganization of actin and, ulti-
mately, foot process effacement are hallmarks of glomer-
ular diseases. AngII directly affects the actin cytoskeleton
of podocytes, and, in the long-term, AngII and increased
RAAS contribute to the progression of glomerular injury
(6). AngII depolarizes glomerular cells by leading to an
increase of cytosolic calcium concentration and, in podo-
cytes, by activation of a calcium-dependent Cl2 conduc-
tance (50).Moreover,AngII induces a shift of thepodocyte
phenotype from a dynamically stable type to an adap-
tively migratory type. This is conferred among others via
the influence on the actin cytoskeleton (12).
Glomerular diseases that are caused by diabetes, hy-
pertension, or immunologic processes represent themajor
cause of chronic kidney disease, which affects more than
5%of thepopulationworldwide. Therapeutic inhibitionof
AngII signaling via administration of AT1R blocker and
angiotensin-converting enzyme inhibitors lowers mortal-
ity and may delay disease progression and, thus, is rec-
ommended formost patients with chronic kidney disease.
Additionalunderstandingof themolecular actionofAngII
in podocytes will lead to the identification of novel treat-
ment strategies.
The aim of our current study was to obtain greater in-
sight into intracellular AngII/AT1R pathway-dependent
phosphorylation and, especially, to identify which kinases
contribute to the signal transduction processes. Therefore,
we employed an SILAC-based approach and analyzed
changes in the phosphoproteome in podocytes after short-
termtreatmentwithAngII.Withthis technique,weidentified
6323 independent phosphopeptides that corresponded to
2081 different proteins. More than three fourths of pro-
teins identified in our screen have been previously found
in a non–phospho-specific characterization of the mouse
whereas the other pictures were obtained at the indicated time points after stimulation. B) Representative live cell imaging
experiment of podocytes that were transiently transfected with ﬂuorescent RFP-LCP1-S5A or -S5E stimulated with AngII
(100 nM). The image labeled 0 min was taken before stimulation, whereas the other pictures were obtained at the indicated time
points after stimulation. C) Quantiﬁcation of cell enlargement after stimulation from live cell experiments using ImageJ. RFP-
labeled cell areas at time point 0 min were determined as unstimulated values and at time point 15 min as stimulated values. The
ratio of cell areas is shown (n $ 3, mean 6 SD, Student’s t test). *P , 0.05, **P , 0.01, ***P , 0.001.
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Figure 7. AngII-induced membrane rufﬂing is predominantly Ca2+ dependent. A) Schematic overview of LCP1 deletion mutants
without EF-binding sites [actin-binding domain (ABD)]. B) Representative live cell imaging experiment of podocytes that were
transiently transfected with ﬂuorescent RFP-LCP1-WT (lines 1 and 4) or the 2 deletion mutants as indicated (lines 2 and 3). For
the experiment in line 4, intracellular and extracellular Ca2+ concentration was reduced. Stimulation of cells was performed by
adding AngII (100 nM). The image labeled “0 min” was taken before stimulation, whereas the other pictures were obtained at the
indicated time points after stimulation. C) Quantiﬁcation of cell enlargement after stimulation from live cell experiments. RFP-
labeled cell areas at time point 0 min were determined as unstimulated values and at time point 15 min as stimulated values using
ImageJ. The ratio of cell areas is shown (n $ 3, means 6 SD, Student’s t test). *P , 0.05, **P , 0.01, ***P , 0.001.
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podocyte proteome (34), which validated the outcome of
this SILAC approach. Of interest, one fourth of proteins
identified in our approach are new and had not been iden-
tified in the mouse podocyte proteome, likely as a result of
thephospho-enrichmentofproteinsofourpodocytecell line.
One hundred twenty-one of the phosphoproteins that
were increased in our study were also regulated in a pre-
vious study with AT1R-overexpressing HEK293 cells,
which suggests that the 323 novel proteins identified in
this study could be podocyte specific (35).
A large number of identified phosphopeptides cor-
respond to extracellular matrix proteins (Table 1). Ex-
pression of these proteins in the human kidney and
their phosphorylation at extracellular residues has also
been observed in prior studies (51–53); however, the
significance of their increased phosphorylation as ob-
served in cell lysates is unknown and should be
addressed in future studies.
Our data demonstrate a predominant phosphorylation
of actin filament–associated proteins, which is in accor-
dance with other studies in HEK293 cells (22, 35, 54) and
indicates that AngII-induced phosphomodification of ac-
tin cytoskeleton–associated proteins could be a common
feature in different cell types (Fig. 2D).
Although AngII-induced regulation of the cytoskeleton
has been previously implicated in podocyte pathology, the
exact mechanisms of cytoskeletal rearrangement upon
AngII exposure are elusive. Podocytes are unique cells at
the glomerular slit diaphragm. To fulfill their function as a
filter, they require an intact and flexible actin cytoskeleton.
On this basis, the strong AngII-induced increase in phos-
phorylation of actin-associated protein LCP1 at Ser5 (factor
4.77; Table 1) stood out among the most enriched phos-
phopeptides in our screen. LCP1 belongs to the a-actinin
protein familyandis involved inactincross-linkingandactin
bundling. Although this protein was found in several other
proteomics studies (https://hpcwebapps.cit.nih.gov/ESBL/Da-
tabase/PodocyteProteome/index.html), to our knowledge, ours
is the first study to focus on the AngII-dependent phos-
phorylation of LCP1, and we have demonstrated LCP1
protein expression and its phosphorylation upon AngII
treatment on the protein level in podocytes. To assess
whether AngII-induced LCP1 phosphorylation was a con-
sequence of AngII-induced intracellular Ca2+ increase, we
treatedpodocyteswith the ionophore ionomycin; however,
ionomycin did not lead to increased LCP1 Ser5 phosphor-
ylation, which suggests that amere increase in intracellular
Ca2+ is not sufficient for LCP1phosphorylation. In contrast,
treatment of podocytes with ATP resulted in LCP1 phos-
phorylation, which is similar to the effect of AngII. Unlike
ionomycin, AngII and ATP ligands signal via activation of
GPCRs that ensure well-balanced local modulation of the
intracellular Ca2+ concentration. In addition to this, GPCR
activation triggers multiple signal-transduction cascades,
which suggests that kinases that aredownstreamofAngII/
AT1R lead to phosphorylation of LCP1.
Similar to that in breast cancer cells (39), LCP1 phos-
phorylation in podocytes was influenced by ERK, RSK,
PKA, and PKC activity (Fig. 3), which suggests that LCP1
phosphorylation by these kinases is not limited to certain
cell types and is also present in podocytes.
Immunofluorescence experiments demonstrated an
AngII-dependent LCP1 targeting to the cell margins (Fig.
4). Moreover, membrane ruffling and alterations of cell–
cell contacts correlated with an increased cell–cell clus-
tering after AngII stimulation. A correlation of LCP1
redistribution, membrane ruffling, and actin binding has
previously been observed by other groups. For example,
treatment of LCP1 MCF-7 breast carcinoma cells with
phorbol 12-myristate 13-acetate, which is a potent activa-
tor of conventional and novel PKC family members (55),
also led to increased LCP1 phosphorylation, LCP1 reloc-
alization, and membrane ruffling (40). Furthermore,
phosphomimicking LCP1-S5E was observed to accumu-
late in actin-rich regions in monkey kidney epithelial cells
(Vero cells) (27). Ser5 phosphorylation has been described
to modulate the actin dynamics in focal adhesions, which
suggests that LCP1 redistribution to de novo assembled
actin-rich structures depends on phosphorylation (40).
However, the authors admitted that nonphosphorylatable
LCP1-S5A also shifted to cell margins after treatment with
phorbol 12-myristate 13-acetate, but to a lesser degree (40).
This result is in line with our live cell experiments. Treat-
ment of podocyteswith anRSK inhibitor,which effectively
inhibited LCP1 phosphorylation (Fig. 3A), could not sup-
press membrane ruffling, lamellipodia formation, and cell
area enlargement after AngII stimulation in LCP1-WT–,
LCP1-S5A–, or LCP1-S5E–transfected cells (Fig. 6). This
indicates that membrane ruffling and lamellipodia forma-
tion do not strictly require LCP1 phosphorylation.
It is known that increased calcium concentrations neg-
atively regulate the actin-bundling activity of LCP1 (46). It
has been recently shown that LCP1 contains a switch helix
structure that, in the presence of calcium, tightly binds to
EF-hand motifs (47). This conformational change reduces
the actin-bundling capacity of LCP1 in the presence of
calcium. Our results suggest that calcium-dependent reg-
ulation of actin bundling is crucial for lamellipodia for-
mation as the expression of the deletion mutants without
calcium binding capacity or a reduction in calcium con-
centration prevented a successful lamellipodia formation
with cell area enlargement (Fig. 7).
Otherwise we could show that LCP1 phosphorylation
influences filopodia formation (Fig. 5) as in contrast to
podocytes expressing the nonphosphorylatable mutant of
LCP1 (LCP1-S5A) podocytes expressing the phosphor-
ylatable (LCP1-WT) or phosphomimicking form (LCP1-
S5E) of LCP1 formed an increased number of prolonged
filopodia. Of interest, a group investigating the influence
of recombinant LCP1 single-domain Abs that bind to dif-
ferent regions of LCP1 also observed an influence on filo-
podia formation comparable to our results (45). One of the
examined Abs inhibited the formation of long filopodia.
This Ab bound to the second actin-binding domain of
LCP1, which led to the conclusion that the actin-bundling
activity of LCP1 plays a fundamental role in filopodia in-
tegrity. Actin bundling activity is influenced by LCP1
phosphorylation (40). In general, actin-bundling proteins,
among other plastins, are involved in the assembly of
filopodia (56).AnaccumulationofLCP1 in focal adhesions
andmembraneprotrusions has beendescribed previously
(27, 40). It could be demonstrated that phosphorylation of
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LCP1 increases its association rate to actin in focal adhe-
sions, thereby decreasing the dissociation rate of F-actin
(40). In epithelial cells, filopodia are important for cell–cell
contacts and cell migration (56); therefore, increased cell
clustering and altered cell–cell contact formation in
podocytes after AngII stimulation might be connected
with changed filopodia formation as a result of LCP1
phosphorylation.
From all these results, it is tempting to speculate that
both the phosphorylation of LCP1 and calcium binding
influence the actin-bundling activity of LCP1, but in dif-
ferent ways and upon different triggers. Consequently,
AngII stimulation has diverse and, in part, competitive
effects on LCP1 activity, the effect of membrane ruffling
and lamellipodia formation obviously overlaying the ef-
fect of filopodia formation.
Expression of LCP1 in podocytes in vivo has also been
found in other proteomic studies. LCP1 expression is not
over-represented in podocytes and seemed to be low (57,
58); however, a low expression level does not exclude an
important role in the regulation or modulation of AngII-
dependent actin cytoskeleton rearrangements in podo-
cytes. In this context, it is of special interest that podocytes
not only expressLCPbut alsoT-plastin; therefore, itwill be
interesting to investigate whether the expression of both
plastins and/or the phosphorylation of LCP1 is increased
during podocyte injury.
Considering the importance of the intact actin cyto-
skeleton, AngII-dependent changes in the phosphoryla-
tion of LCP1 or other actin-associated proteins, such as
palladin, that facilitates G- and F-actin binding and the
targeting of actin to specific foci (59) might contribute to
podocyte viability or damage (Table 1).
Taken together, our study highlights the relevance of
AngII-induced phosphorylation of actin-associated
proteins and, thus, the regulation of actin dynamics in
podocytes. Themain phosphorylation cascades that are
activated by AngII seem to be conserved, but appar-
ently AngII signaling in podocytes is complemented by
podocyte-specific signal transduction. LCP1 might act
as a signal-integrating molecule and coregulator of ac-
tin dynamics upon different GPCR-dependent—in this
case, AngII/AT1R—signaling cascades. Although addi-
tional studies are needed, the development of drugs that
target the cytoskeletal turnover of actin-modulating pro-
teins would be a promising approach for the treatment of
diseases of the podocyte.
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